XBiotech Inc. (XBIT): Price and Financial Metrics

XBIT POWR Grades

• XBIT scores best on the Value dimension, with a Value rank ahead of 88.7% of US stocks.
• The strongest trend for XBIT is in Momentum, which has been heading down over the past 52 weeks.
• XBIT's current lowest rank is in the Momentum metric (where it is better than 4.46% of US stocks).

XBIT Stock Summary

• XBiotech Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 10.85% of US listed stocks.
• For XBIT, its debt to operating expenses ratio is greater than that reported by merely 0.5% of US equities we're observing.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.02 for XBiotech Inc; that's greater than it is for just 5.71% of US stocks.
• Stocks that are quantitatively similar to XBIT, based on their financial statements, market capitalization, and price volatility, are MNOV, ACRS, RESN, IONS, and CCXI.
• XBIT's SEC filings can be seen here. And to visit XBiotech Inc's official web site, go to www.xbiotech.com.

XBIT Valuation Summary

• XBIT's price/sales ratio is 19.3; this is 70.04% higher than that of the median Healthcare stock.
• XBIT's price/sales ratio has moved NA NA over the prior 78 months.
• Over the past 78 months, XBIT's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for XBIT.

XBIT Growth Metrics

• Its year over year revenue growth rate is now at 185.2%.
• Its 4 year net cashflow from operations growth rate is now at -102.23%.
• The 3 year net cashflow from operations growth rate now stands at 51.84%.

Over the past 49 months, XBIT's revenue has gone up $25,193,000.

The table below shows XBIT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	25.193	81.698	-12.05
2021-03-31	36.166	-2.667	-13.776
2020-12-31	43.997	-65.149	-11.221
2020-09-30	38.728	-68.504	677.111
2020-06-30	28.179	-80.971	673.487
2020-03-31	12.681	-74.266	674.479

XBIT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XBIT has a Quality Grade of D, ranking ahead of 12.96% of graded US stocks.
• XBIT's asset turnover comes in at 0.071 -- ranking 293rd of 681 Pharmaceutical Products stocks.
• QLGN, CPHI, and DRNA are the stocks whose asset turnover ratios are most correlated with XBIT.

The table below shows XBIT's key quality metrics over time.